KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $17.0 million.

  • Teladoc Health's Share-based Compensation fell 5008.08% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.0 million, marking a year-over-year decrease of 4435.94%. This contributed to the annual value of $146.0 million for FY2024, which is 2758.57% down from last year.
  • Latest data reveals that Teladoc Health reported Share-based Compensation of $17.0 million as of Q3 2025, which was down 5008.08% from $22.3 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Share-based Compensation ranged from a high of $86.3 million in Q1 2021 and a low of $17.0 million during Q3 2025
  • Its 5-year average for Share-based Compensation is $49.1 million, with a median of $50.8 million in 2022.
  • Within the past 5 years, the most significant YoY rise in Teladoc Health's Share-based Compensation was 37119.85% (2021), while the steepest drop was 8513.08% (2021).
  • Teladoc Health's Share-based Compensation (Quarter) stood at $61.6 million in 2021, then dropped by 17.63% to $50.8 million in 2022, then fell by 7.75% to $46.8 million in 2023, then plummeted by 41.33% to $27.5 million in 2024, then tumbled by 38.13% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $22.3 million for Q2 2025, and $25.2 million during Q1 2025.